Format

Send to

Choose Destination
Leukemia. 2019 Feb;33(2):554-558. doi: 10.1038/s41375-018-0274-y. Epub 2018 Oct 12.

Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials.

Author information

1
Public Health Division and SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. mothus@fredhutch.org.
2
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
3
Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
4
Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
5
Department of Laboratory Medicine, Division of Hematopathology, University of Washington, Seattle, WA, USA.
6
Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
7
Providence Cancer Center Oncology and Hematology Care Clinic, Portland, OR, USA.
8
VA Medical Center, North Palm Beach, FL, USA.
9
Katmai Oncology Group, Anchorage, AK, USA.
10
University of Alabama at Birmingham, Birmingham, AL, USA.
11
Duke University, Durham, NC, USA.
12
Department of Epidemiology, University of Washington, Seattle, WA, USA.
PMID:
30315233
PMCID:
PMC6367002
[Available on 2019-08-01]
DOI:
10.1038/s41375-018-0274-y

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center